Fa. Wenger et al., Effects of octreotide on liver metastasis and intrametastatic lipid peroxidation in experimental pancreatic cancer, ONCOL-BASEL, 60(3), 2001, pp. 282-288
Objectives: In prospective clinical trials, octreotide improved the quality
of life and survival time in patients with pancreatic cancer, in this stud
y, we analyzed whether octreotide modulates the intrametastatic oxygen radi
cal metabolism and might decrease liver metastasis in a model of pancreatic
cancer. Methods: Syrian hamsters received 0.9% NaCl or N-nitrosobis(2-oxop
ropyl)amine for 3 months, Therapy was performed for 12 weeks by 0.9% NaCl o
r octreotide, Hamsters received a standard diet or were fed a high-fat diet
, In the 25th week, pancreas and liver were examined macroscopically and hi
stologically, The level of lipid peroxidation and the activity of glutathio
ne peroxidase and superoxide dismutase were determined intrahepatically and
intrametastatically, Results: The number and size of liver metastases per
animal were increased by high-fat diet and decreased by octreotide. While h
igh-fat diet increased intrahepatic extrametastatic lipid peroxidation, oct
reotide decreased intrahepatic extrametastatic lipid peroxidation and incre
ased intrametastatic lipid peroxidation. Conclusions: Octreotide decreases
the number and size of liver metastases in chemically induced pancreatic ca
ncer in Syrian hamsters, Possible mechanisms are the prevention of high lip
id peroxidation in non-metastatic liver as well as the increase in intramet
astatic lipid peroxidation, leading to loss of integrity of spread tumor ce
lls, Copyright (C) 2001 S. Karger AG, Basel.